Interrupting Therapy for Pregnancy Did Not Increase Risk of Breast Cancer Recurrence
Interrupting adjuvant endocrine therapy to attempt pregnancy does not increase the risk of breast cancer recurrence, a study suggests.
Interrupting adjuvant endocrine therapy to attempt pregnancy does not increase the risk of breast cancer recurrence, a study suggests.
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Breast cancer patients who receive a peritumoral injection of lidocaine immediately before surgery have better survival outcomes, a study suggests.
More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study suggests.
Researchers sought to determine if decision making regarding managing breast cancer risk differed between women of different races at above average risk.
Researchers sought to determine if fear of recurrence therapy could improve outcomes for survivors of breast and gynecologic cancers.
In patients whose tumors had ESR1 mutations, elacestrant reduced the risk of progression or death by 45%.
Radiotherapy after breast-conserving surgery can be omitted in women aged 65 years or older who have grade 1-2, ER-high breast cancer, as long as they receive 5 years of adjuvant endocrine therapy, according to researchers.
LGBTQ+ patients with breast cancer experience delayed diagnosis and worse outcomes than cisgender heterosexual patients, a study suggests.
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.